AeroGrow International 10-Q 10 Nov 16 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Sep. 30, 2016	Nov. 03, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	AeroGrow International, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		8,597,093
Amendment Flag	false
Entity Central Index Key	1,316,644
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016
Current assets
Cash	$ 399	$ 1,401
Restricted cash	15	15
Accounts receivable, net of allowance for doubtful accounts of $17 and $14 at September 30, 2016 and March 31, 2016, respectively	1,775	1,577
Other receivables	85	232
Inventory	5,510	3,149
Prepaid expenses and other	948	196
Total current assets	8,732	6,570
Property and equipment, net of accumulated depreciation of $3,837 and $3,652 at September 30, 2016 and March 31, 2016, respectively	545	620
Other assets
Intangible assets	2	2
Deposits	106	156
Total assets	9,385	7,348
Current liabilities
Accounts payable	2,533	1,733
Accrued expenses	851	964
Customer deposits	195	352
Deferred rent		1
Notes payable-related party	2,759	1,293
Derivative warrant liability	1,547	644
Debt associated with sale of intellectual property	138	160
Total current liabilities	8,023	5,147
Long term liabilities
Capital lease liability	21
Total liabilities	8,044	5,147
Commitments and contingencies
Stockholders’ equity
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 issued and outstanding at September 30, 2016 and March 31, 2016	3	3
Common stock, $.001 par value, 750,000,000 shares authorized, 8,579,006 and 7,499,966, shares issued and outstanding at September 30, 2016 and March 31, 2016, respectively	9	7
Additional paid-in capital	86,896	84,129
Stock to be distributed for Scotts Miracle-Gro transactions	1,195	2,391
Accumulated deficit	(86,762)	(84,329)
Total stockholders’ equity	1,341	2,201
Total liabilities and stockholders’ equity	$ 9,385	$ 7,348

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016
Allowance for doubtful accounts (in Dollars)	$ 17	$ 14
Accumulated depreciation (in Dollars)	$ 3,837	$ 3,652
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	2,649,007	2,649,007
Preferred stock, shares outstanding	2,649,007	2,649,007
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	8,579,006	7,499,966
Common stock, shares outstanding	8,579,006	7,499,966

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net revenue	$ 2,242	$ 1,091	$ 4,398	$ 2,660
Cost of revenue	1,551	761	2,863	1,849
Gross profit	691	330	1,535	811
Operating expenses
Research and development	114	143	211	274
Sales and marketing	729	668	1,549	1,301
General and administrative	475	561	1,055	1,235
Total operating expenses	1,318	1,372	2,815	2,810
(Loss) from operations	(627)	(1,042)	(1,280)	(1,999)
Other income (expense), net
Fair value changes in derivative warrant liability	(458)	(66)	(903)	(330)
Interest expense – related party	(27)	(58)	(31)	(58)
Other expense	(16)	0	(41)	0
Total other (expense), net	(501)	(124)	(975)	(388)
Net loss	(1,128)	(1,166)	(2,255)	(2,387)
Change in fair value of stock and dividend to be distributed for Scotts Miracle-Gro transactions	(317)	1,177	(767)	1,398
Net income (loss) attributable to common shareholders	$ (1,445)	$ 11	$ (3,022)	$ (989)
Net loss per share, basic and diluted (in Dollars per share)	$ (0.17)	$ 0	$ (0.37)	$ (0.14)
Weighted average number of common shares outstanding, basic and diluted (in Shares)	8,576	7,500	8,138	7,102

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net (loss)	$ (2,255)	$ (2,387)
Adjustments to reconcile net (loss) to cash used by operations:
Issuance of common stock and options under equity compensation plans	92	157
Depreciation and amortization expense	185	179
Bad debt (recovery) expense	3	(5)
Fair value remeasurement of derivative warrant liability	903	330
Accretion of debt associated with sale of intellectual property	(22)	(24)
SMG intellectual property royalty and branding license	217	123
Change in operating assets and liabilities:
Decrease (increase) in accounts receivable	(201)	673
Decrease in other receivable	147	149
(Increase) in inventory	(2,361)	(1,559)
(Increase) in prepaid expense and other	(752)	(997)
Decrease in deposits	50	0
Increase in accounts payable	1,589	821
(Decrease) in accrued expenses	(113)	(192)
Increase in accrued interest-related party	13	58
(Decrease) in customer deposits	(157)	(25)
(Decrease) increase in deferred rent	(1)	1
Net cash used by operating activities	(2,663)	(2,698)
Cash flows from investing activities:
Purchases of equipment	(88)	(406)
Net cash (used) by investing activities	(88)	(406)
Cash flows from financing activities:
Proceeds from notes payable	2,750	4,500
Repayment of notes payable-related party	(1,000)	0
Repayment of capital lease	(1)	0
Net cash provided by financing activities	1,749	4,500
Net (decrease) increase in cash	(1,002)	1,396
Cash, beginning of period	1,401	1,015
Cash, end of period	399	2,411
Cash paid during the year for:
Interest	18	0
Income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment acquired through capital lease	22	0
Decrease in liability due to issuance of stock to SMG on notes payable – related party	297	207
Fair value of common stock issued for payment of interest on notes payable-related party	480	431
Change in fair value of common stock issued for payment of interest on notes payable-related party at issuance	183	224
Change in fair value of SMG intellectual property royalty, branding license and interest on notes payable-related party	(946)	679
Change in fair value of stock dividends for common stock issued on convertible preferred stock	530	434
Change in fair value of stock dividends accrued on convertible preferred stock	(534)	61
Decrease in liability due to issuance of stock to SMG for intellectual property and branding license	$ 1,006	$ 887

1. Description of Business

1. Description of Business	6 Months Ended
	Sep. 30, 2016
Disclosure Text Block [Abstract]
Business Description and Basis of Presentation [Text Block]	1. Description of Business AeroGrow International, Inc. (the “Company,” “AeroGrow,” “we,” “our,” or “us”) was formed as a Nevada corporation on March 25, 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide. The Company manufactures, distributes and markets seven different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution via brick and mortar, storefronts and .com retail outlets, catalogue and direct-to-consumer sales primarily in the United States and Canada, as well as selected countries in Europe, Asia and Australia.

2. Liquidity and Basis of Prese

2. Liquidity and Basis of Presentation	6 Months Ended
	Sep. 30, 2016
Disclosure Text Block [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	2. Liquidity and Basis of Presentation Interim Financial Information The unaudited interim financial statements of the Company included herein have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim reporting including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These condensed statements do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for annual audited financial statements and should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2016, as filed with the SEC on June 15, 2016. In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, including normal recurring adjustments, necessary to present fairly the financial position of the Company at September 30, 2016, the results of operations for the three and six months ended September 30, 2016 and 2015, and the cash flows for the six months ended September 30, 2016 and 2015. The results of operations for the three and six months ended September 30, 2016 are not necessarily indicative of the expected results of operations for the full year or any future period. In this regard, the Company’s business is highly seasonal, with approximately 70.9% of revenues in the fiscal year ended March 31, 2016 (“Fiscal 2016”) occurring in the four consecutive calendar months of October through January. Furthermore, during the six-month period ended September 30, 2016, the Company has further expanded its distribution channel and invested in necessary overhead in anticipation of the peak sales season. The balance sheet as of March 31, 2016 is derived from the Company’s audited financial statements. Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, cash flow from operations, and borrowings under the Company’s debt arrangements. On July 15, 2016, the Company entered into a Term Loan Agreement in the principal amount of up to $6.0 million with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with its subsidiary, “SMG” or “Scotts Miracle-Gro”). See Note 3 “Notes Payable, Long Term Debt and Current Portion – Long Term Debt” below. Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is reasonably possible that a change in the Company’s estimates could occur in the near term as additional or new information becomes available. Net Income (Loss) per Share of Common Stock The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260. ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”). Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if it had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. Employee stock options to purchase approximately 656,000 shares of common stock were outstanding and warrants to purchase approximately 432,000 shares of common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been anti-dilutive in the periods presented. Concentrations of Risk ASC 825-10-50-20 Customers: For the three months ended September 30, 2016, the Company had three customers, Amazon.com, Sur La Table and Ace Hardware, which represented 33.3%, 20.1% and 16.8% of net revenue, respectively. For the three months ended September 30, 2015, the Company had one customer, Amazon.com, which represented 42.4% of the Company’s net revenue. For the six months ended September 30, 2016, the Company had one customer, Amazon.com that represented 34.6% of the Company’s net revenue. For the six months ended September 30, 2015, the Company had had one customer, Amazon.com that represented 40.1% of the Company’s net revenue. Suppliers: For the three months ended September 30, 2016, the Company purchased inventories and other inventory-related items from one supplier totaling $3.6 million, representing 233.2% of cost of revenue, as we ramp up inventory levels for the holiday season. For the three months ended September 30, 2015, the Company purchased inventories and other inventory-related items from four suppliers totaling $2.2 million, $315,000, $167,000 and $149,000, representing 206.2%, 29.1%, 15.4% and 13.7% of cost of revenue, respectively. For the six months ended September 30, 2016, the Company purchased inventories and other inventory-related items from one supplier totaling $4.1 million, representing 142.3% of cost of revenue. For the six months ended September 30, 2015, the Company purchased inventories and other inventory-related items from one supplier totaling $2.6 million, representing 43.3% of cost of revenue. The Company’s primary contract manufacturers are located in China. As a result, the Company may be subject to political, currency, regulatory, transportation, third-party labor and weather/natural disaster risks. Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on our operations. Accounts Receivable: As of September 30, 2016, the Company had three customers, Amazon.com, Sur La Table and Ace Hardware that represented 35.3%, 26.2% and 21.3%, respectively, of the Company’s outstanding accounts receivable. As of March 31, 2016, the Company had two customers, Amazon.com and Costco that represented 35.3% and 22.1%, respectively, of outstanding accounts receivable. The Company believes that all receivables from these customers are collectible. Fair Value of Financial Instruments The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants. ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3. Level 1 – Quoted prices in active markets for identical assets. Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations. Level 3 – Unobservable inputs that are supported by little or no market activity. The carrying value of financial instruments including cash, receivables, accounts payable and accrued expenses, approximates their fair value at September 30, 2016 and March 31, 2016 due to the relatively short-term nature of these instruments. The Company has three liabilities for which the carrying value is determined by Level 3 inputs: (1) Notes payable – related party; (2) sale of intellectual property liability; and (3) derivative warrant liability. As discussed below in Notes 3 and 4, each of these liabilities was incurred in conjunction with the Company’s strategic alliance with Scotts Miracle-Gro. As of September 30, 2016 and March 31, 2016, the fair value of the Company’s note payable and sale of intellectual property liability were estimated using the discounted cash flow method, which is based on expected future cash flows, discounted to present value using a discount rate of 15%. The Company also issued a derivative warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, would constitute 80% of the Company’s outstanding capital stock. The Company accounts for the warrant as a liability and measures the value of the warrant using the Monte Carlo simulation model as of the end of each quarterly reporting period until the warrant is exercised or expires. As of September 30, 2016 and March 31, 2016, the estimated fair value of the warrant was $1.5 million and $644,000, respectively. As of September 30, 2016, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition, except for the derivative warrant liability. The table below summarizes the fair value and carry value of each Level 3 category liability: September 30, 2016 (in thousands) March 31, 2016 (in thousands) Fair Value Carry Value Fair Value Carry Value Liabilities Notes payable-related party $ 2,716 $ 2,759 $ 1,277 $ 1,293 Derivative warrant liability 1,547 1,547 644 644 Sale of intellectual property liability 104 138 117 160 Total $ 4,367 $ 4,444 $ 2,038 $ 2,097 Accounts Receivable and Allowance for Doubtful Accounts The Company sells its products to retailers and directly to consumers. Direct-to-consumer transactions are primarily paid by credit card. Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days. Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company’s allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $17,000 and $14,000 at September 30, 2016 and March 31, 2016, respectively. Other Receivables In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of September 30, 2016 and March 31, 2016, the balance in this reserve account was $85,000 and $232,000, respectively. Advertising and Production Costs The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed. The Company records media costs related to its direct-to-consumer advertisements, inclusive of related postage and printing costs incurred in conjunction with mailings of catalogues, in accordance with ASC 340-20 Capitalized Advertising Costs Advertising expense for the three and six months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, (in thousands) Six Months Ended September 30, (in thousands) 2016 2015 2016 2015 Direct-to-consumer $ 36 $ 61 $ 115 $ 198 Retail 107 95 302 96 Other 7 11 15 24 Total advertising expense $ 150 $ 167 $ 432 $ 318 As of September 30, 2016 and March 31, 2016, the Company deferred $1,000 and $24,000, respectively, related to such media and advertising costs, including the catalogue cost described above. The costs are included in the prepaid expenses and other line of the condensed balance sheets. Inventories Inventories are valued at the lower of cost, determined on the basis of standard costing, which approximates the first-in, first-out method, or net realizable value. When the Company is the manufacturer, raw materials, labor, and manufacturing overhead are included in inventory costs. The Company records raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing September 30, March 31, 2016 (in thousands) 2016 (in thousands) Finished goods $ 4,484 $ 2,372 Raw materials 1,026 777 $ 5,510 $ 3,149 The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of September 30, 2016 and March 31, 2016, the Company had reserved $285,000 for inventory obsolescence. Revenue Recognition The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists, including the following; (i) a product is shipped under an agreement with a customer; (ii) the risk of loss and title has passed to the customer; (iii) the fee is fixed or determinable; and (iv) collection of the resulting receivable is reasonably assured. The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives. Certain incentive programs require the Company to estimate the number of customers who will actually redeem the incentive based on historical industry experience. As of September 30, 2016 and March 31, 2016, the Company had accrued $105,000 and $151,000, respectively, as an estimate for the foregoing deductions and allowances. These expenses are included in the accrued expenses line of the condensed balance sheets. Warranty and Return Reserves The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation. Based upon the foregoing, the Company has recorded a provision for potential future warranty costs of $119,000 and $117,000 as of September 30, 2016 and March 31, 2016, respectively. The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of September 30, 2016 and March 31, 2016, the Company has recorded a reserve for customer returns of $60,000 and $197,000, respectively. Recently Issued Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, “Leases.” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The adoption of this ASU is expected to result in all operating leases being capitalized and a current and long-term liability recorded in the Company’s financial statements. In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes,” which requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position to simplify the presentation of deferred income taxes. The standard is effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The Company has early adopted this ASU and had no material impact on our financial statements. In August 2015, the FASB issued ASU 2015-14 which updated (to defer the effective date by one year) previously issued ASU 2014-09, “Revenue from Contracts with Customers,” which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018 using one of two prescribed retrospective methods. Early adoption is not permitted. We have not yet selected a transition method, nor have we determined the effect of the standard on our ongoing financial reporting. In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory.” Under this ASU, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The ASU defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. Management has early adopted ASU 2015-11 and notes no material impact on the Company’s financial position or results of operations. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” which requires management to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued. This ASU is effective for annual periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016. The adoption of this ASU is not expected to have a material impact on the Company’s financial statements.

3. Notes Payable, Long Term Deb

3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt	6 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	3. Notes Payable, Long Term Debt and Current Portion – Long Term Debt For a detailed discussion on our previously outstanding Notes Payable, Long Term Debt and Current Portion – Long Term Debt, refer to the Company’s Annual Report on Form 10-K for the year ended March 31, 2016, as filed with the SEC on June 15, 2016. The following are the changes to our Notes Payable, Long Term Debt and Current Portion – Long Term Debt for the periods presented. As of September 30, 2016 and March 31, 2016, the outstanding balance of the Company’s notes payable and debt, including accrued interest, is as follows: September 30, 2016 (in thousands) March 31, 2016 (in thousands) Notes payable-related party $ 2,759 $ 1,293 Derivative warrant liability (see Note 4) 1,547 644 Sale of intellectual property liability (see Note 4) 138 160 Total debt 4,444 2,097 Less notes payable and current portion – long term debt 4,444 2,097 Long term debt $ - $ - Scotts Miracle-Gro Term Loan On July 15, 2016, AeroGrow entered into a Term Loan Agreement in the principal amount of up to $6.0 million with Scotts Miracle- Gro (“SMG Term Loan”). The proceeds will be made available as needed in increments of $500,000 not to exceed $6.0 million with a due date th Liabilities Associated with Scotts Miracle-Gro Transaction On April 22, 2013, the Company issued Series B Convertible Preferred Stock and a warrant to a wholly-owned subsidiary of Scotts Miracle-Gro. Pursuant to U.S. GAAP, the Company has classified the warrant as a liability at its estimated fair value. The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires. The valuation techniques used to determine the fair value of the derivative warrant liability and the terms of the warrant are further explained in Note 4. As of September 30, 2016 and March 31, 2016, the estimated fair value of the warrant was $1.5 million and $644,000, respectively. The Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement. The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Because the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of revenue, and has significant involvement in the generation of its revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method. As of September 30, 2016 and March 31, 2016, a liability of $138,000 and $160,000, respectively, was recorded on the balance sheets for the Intellectual Property Sale Agreement. As of September 30, 2016 and March 31, 2016, a liability of $263,000 and $579,000, respectively, was recorded on the balance sheets for the Technology Licensing Agreement. The accrued liability for the Brand License Agreement at $1.51 per share is fair valued at period end and recorded as stock dividend to be distributed and amounts to $454,000 and $905,000 of the stock dividend to be distributed as of September 30, 2016 and March 31, 2016, respectively.

4. Scotts Miracle-Gro Transacti

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions	6 Months Ended
	Sep. 30, 2016
Convertible Preferred Stock Warrants And Other Transactions [Abstract]
Convertible Preferred Stock Warrants And Other Transactions [Text Block]	4. Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions Series B Convertible Preferred Stock and Related Transactions On April 22, 2013, the Company entered into a Securities Purchase Agreement with Scotts Miracle-Gro. Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2,649,007 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4.0 million. After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds totaled to $3.8 million. The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power who was a former supplier of product. The Series B Convertible Preferred Stock is convertible into 2,649,007 shares of the Company’s common stock ($4.0 million divided by a conversion price of $1.51 per share). The Series B Convertible Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Convertible Preferred Stock Certificates of Designations). The Series B Convertible Preferred Stock does not have a liquidation preference and is entitled to vote on an “as-converted” basis with the common stock. The stock dividend accrues from day to day and is payable in shares of our common stock within thirty days after the end of each fiscal year end. The stock dividend issuable is recorded at the fair market value of our common stock at the end of each quarter in the equity section of the balance sheet. The corresponding charge will be recorded below net income to arrive at net income available to common shareholders. The Series B Convertible Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Convertible Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Convertible Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Convertible Preferred Stock and such exercise of the Warrant. The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise. The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date, respectively). In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time. The exercise price of the Warrant shall be equal to the quotient obtained by dividing: (a) an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant), by (b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering. The Warrant expires on April 22, 2021, the eighth anniversary of the closing date. The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets). Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuances of the Company’s equity securities. Upon exercise of the Warrant and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter. The private offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act. Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act. Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration. The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Convertible Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013. The warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $1.5 million and $644,000 as of September 30, 2016 and March 31, 2016, respectively. The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires. The Company calculated the fair value of the Warrant during the quarter ended September 30, 2016 using a Monte Carlo simulation model. In June 2016, representatives of Scotts Miracle-Gro informed our management team and our Board of Directors of its intent to exercise some or all of the Warrant prior to December 31, 2016. In conjunction with the private offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement. The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. For more details regarding these agreements, please refer to Note 3 “Scotts Miracle-Gro Transactions” to the financial statements included in the Company’s Annual Report on Form 10-K, as filed with the SEC on June 15, 2016. See also Note 3 for the Term Loan with Scotts Miracle-Gro.

5. Equity Compensation Plans

5. Equity Compensation Plans	6 Months Ended
	Sep. 30, 2016
Share-based Arrangements with Employees and Nonemployees [Abstract]
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	5. Equity Compensation Plans For the three and six months ended September 30, 2016, the Company did not grant options to purchase shares of common stock under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”). For the three and six months ended September 30, 2015, the Company granted options to purchase 212,000 shares of common stock under the 2005 Plan. During the three and six months ended September 30, 2016, no options to purchase shares of common stock were cancelled or expired. During the three and six months ended September 30 2016, no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan. During the three and six months ended September 30, 2015, no options to purchase shares of common stock were cancelled or expired. During the three and six months ended September 30, 2015, no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan. As of September 30, 2016, unvested options to purchase an aggregate of 72,000 shares of the Company’s common stock were outstanding. The Company will incur up to $60,000 of compensation expense in future periods if these options fully vest. Information regarding all stock options outstanding under the 2005 Plan as of September 30, 2016 is as follows: OPTIONS OUTSTANDING OPTIONS EXERCISABLE Exercise price Options (in thousands) Weighted-average Remaining Contractual Life (years) Weighted-average Exercise Price Aggregate Intrinsic Value (in thousands) Options (in thousands) Weighted-average Remaining Contractual Life (years) Weighted- average Exercise Price Aggregate Intrinsic Value (in thousands) $ 1.01 79 1.35 $ 1.01 79 1.35 $ 1.01 $ 1.10 50 1.50 $ 1.10 50 1.50 $ 1.10 $ 1.21 50 1.50 $ 1.21 50 1.50 $ 1.21 $ 1.55 212 3.88 $ 1.55 140 3.88 $ 1.55 $ 2.20 162 1.99 $ 2.20 162 1.99 $ 2.20 $ 2.42 10 2.02 $ 2.42 10 2.02 $ 2.42 $ 5.31 93 2.85 $ 5.31 93 2.85 $ 5.31 656 2.57 $ 2.13 $ 1,628 584 2.41 $ 2.20 $ 1,417 The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented, which was September 30, 2016.

6. Income Taxes

6. Income Taxes	6 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	6. Income Taxes The Company follows the guidance in ASC 740, Accounting for Uncertainty in Income Taxes Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income. Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against such assets where management is unable to conclude more likely than not that such asset will be realized. As of September 30, 2016 and March 31, 2016, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance and the Company has no unrecognized tax benefits related to uncertain tax positions.

7. Related Party Transactions

7. Related Party Transactions	6 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	7. Related Party Transactions See Note 6 “Related Party Transactions” of Form 10-K for the year ended March 31, 2016, as filed with the SEC on June 15, 2016 for a detailed discussion of related party transactions. On July 15, 2016, AeroGrow entered into a Term Loan Agreement in the principal amount of up to $6.0 million with Scotts Miracle-Gro. Interest is charged at the stated rate of 10% per annum and will be paid quarterly in arrears, in cash on the 15th day of each June, September, December and March. See Note 3 “Notes Payable, Long Term Debt and Current Portion – Long Term Debt” above.

8. Stockholders_ Equity

8. Stockholders’ Equity	6 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	8. Stockholders’ Equity A summary of the Company’s common stock warrant activity for the period from April 1, 2016 through September 30, 2016 is presented below: Warrants Outstanding (in thousands) Weighted Average Exercise Price Aggregate Intrinsic Value (in thousands) Outstanding, April 1, 2016 444 $ 6.45 $ 7 Granted - - Exercised 12 2.10 Expired - - Outstanding, September 30, 2016 432 $ 6.57 $ 91 As of September 30, 2016, the Company had the following outstanding warrants to purchase shares of its common stock: Weighted Average Warrants Outstanding (in thousands) Exercise Price Remaining Life (Years) 38 $ 2.10 2.02 394 $ 7.00 0.53 432 $ 6.57 0.66 Preferred Stock and Preferred Stock Warrants As discussed in Note 4, the Company also issued a warrant that entitles, but does not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. The warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value. The warrant liability will be re-measured to fair value at the end of each reporting period until it is exercised or expires. The tables above exclude the warrant issued to Scotts Miracle-Gro because the warrant is not issuable in any certain number of shares, as discussed above. In June 2016, representatives of Scotts Miracle-Gro informed our management team and our Board of Directors of its intent to exercise some or all of the Warrant prior to December 31, 2016. As described in Note 4 above, on April 22, 2013 the Company issued 2,649,007 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share to an affiliate of Scotts Miracle-Gro as part of the Scotts Miracle-Gro Transaction. The Securities Purchase Agreement, Certificates of Designations for the Series B Preferred Stock, Form of Warrant, Indemnification Agreement, Investor’s Rights Agreement and Voting Agreement were filed as exhibits to a Current Report on Form 8-K that was filed with the SEC on April 23, 2013. The Series B Preferred Stock is convertible into 2,649,007 shares of common stock ($4.0 million divided by a conversion price of $1.51 per share). The Series B Convertible Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Convertible Preferred Stock Certificates of Designations). As of September 30, 2016, based on the number of shares issuable to Scotts Miracle-Gro, the Company has accrued $478,000 for the stock dividend. For additional details regarding the Series B Convertible Preferred Stock, see “Note 4 – Scotts Miracle-Gro Transaction” above.

Note 9 - Subsequent Events

Note 9 - Subsequent Events	6 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	9. Subsequent Events In October and November 2016, the Company borrowed an additional $2.5 million on the SMG Term Loan. As disclosed in Note 3 above, the proceeds were made available in increments of at least $500,000 with a due date of April 15, 2017. As of November 3, 2016, the Company had borrowed an aggregate of $5.3 million in principal under the Term Loan.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is reasonably possible that a change in the Company’s estimates could occur in the near term as additional or new information becomes available.
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) per Share of Common Stock The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260. ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”). Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if it had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. Employee stock options to purchase approximately 656,000 shares of common stock were outstanding and warrants to purchase approximately 432,000 shares of common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been anti-dilutive in the periods presented
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Risk ASC 825-10-50-20 Customers: For the three months ended September 30, 2016, the Company had three customers, Amazon.com, Sur La Table and Ace Hardware, which represented 33.3%, 20.1% and 16.8% of net revenue, respectively. For the three months ended September 30, 2015, the Company had one customer, Amazon.com, which represented 42.4% of the Company’s net revenue. For the six months ended September 30, 2016, the Company had one customer, Amazon.com that represented 34.6% of the Company’s net revenue. For the six months ended September 30, 2015, the Company had had one customer, Amazon.com that represented 40.1% of the Company’s net revenue. Suppliers: For the three months ended September 30, 2016, the Company purchased inventories and other inventory-related items from one supplier totaling $3.6 million, representing 233.2% of cost of revenue, as we ramp up inventory levels for the holiday season. For the three months ended September 30, 2015, the Company purchased inventories and other inventory-related items from four suppliers totaling $2.2 million, $315,000, $167,000 and $149,000, representing 206.2%, 29.1%, 15.4% and 13.7% of cost of revenue, respectively. For the six months ended September 30, 2016, the Company purchased inventories and other inventory-related items from one supplier totaling $4.1 million, representing 142.3% of cost of revenue. For the six months ended September 30, 2015, the Company purchased inventories and other inventory-related items from one supplier totaling $2.6 million, representing 43.3% of cost of revenue. The Company’s primary contract manufacturers are located in China. As a result, the Company may be subject to political, currency, regulatory, transportation, third-party labor and weather/natural disaster risks. Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on our operations. Accounts Receivable: As of September 30, 2016, the Company had three customers, Amazon.com, Sur La Table and Ace Hardware that represented 35.3%, 26.2% and 21.3%, respectively, of the Company’s outstanding accounts receivable. As of March 31, 2016, the Company had two customers, Amazon.com and Costco that represented 35.3% and 22.1%, respectively, of outstanding accounts receivable. The Company believes that all receivables from these customers are collectible.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants. ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3. Level 1 – Quoted prices in active markets for identical assets. Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations. Level 3 – Unobservable inputs that are supported by little or no market activity. The carrying value of financial instruments including cash, receivables, accounts payable and accrued expenses, approximates their fair value at September 30, 2016 and March 31, 2016 due to the relatively short-term nature of these instruments. The Company has three liabilities for which the carrying value is determined by Level 3 inputs: (1) Notes payable – related party; (2) sale of intellectual property liability; and (3) derivative warrant liability. As discussed below in Notes 3 and 4, each of these liabilities was incurred in conjunction with the Company’s strategic alliance with Scotts Miracle-Gro. As of September 30, 2016 and March 31, 2016, the fair value of the Company’s note payable and sale of intellectual property liability were estimated using the discounted cash flow method, which is based on expected future cash flows, discounted to present value using a discount rate of 15%. The Company also issued a derivative warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, would constitute 80% of the Company’s outstanding capital stock. The Company accounts for the warrant as a liability and measures the value of the warrant using the Monte Carlo simulation model as of the end of each quarterly reporting period until the warrant is exercised or expires. As of September 30, 2016 and March 31, 2016, the estimated fair value of the warrant was $1.5 million and $644,000, respectively. As of September 30, 2016, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition, except for the derivative warrant liability. The table below summarizes the fair value and carry value of each Level 3 category liability: September 30, 2016 (in thousands) March 31, 2016 (in thousands) Fair Value Carry Value Fair Value Carry Value Liabilities Notes payable-related party $ 2,716 $ 2,759 $ 1,277 $ 1,293 Derivative warrant liability 1,547 1,547 644 644 Sale of intellectual property liability 104 138 117 160 Total $ 4,367 $ 4,444 $ 2,038 $ 2,097
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]	Accounts Receivable and Allowance for Doubtful Accounts The Company sells its products to retailers and directly to consumers. Direct-to-consumer transactions are primarily paid by credit card. Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days. Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company’s allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $17,000 and $14,000 at September 30, 2016 and March 31, 2016, respectively
Receivables, Policy [Policy Text Block]	Other Receivables In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of September 30, 2016 and March 31, 2016, the balance in this reserve account was $85,000 and $232,000, respectively.
Advertising Costs, Policy [Policy Text Block]	Advertising and Production Costs The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed. The Company records media costs related to its direct-to-consumer advertisements, inclusive of related postage and printing costs incurred in conjunction with mailings of catalogues, in accordance with ASC 340-20 Capitalized Advertising Costs Advertising expense for the three and six months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, (in thousands) Six Months Ended September 30, (in thousands) 2016 2015 2016 2015 Direct-to-consumer $ 36 $ 61 $ 115 $ 198 Retail 107 95 302 96 Other 7 11 15 24 Total advertising expense $ 150 $ 167 $ 432 $ 318 As of September 30, 2016 and March 31, 2016, the Company deferred $1,000 and $24,000, respectively, related to such media and advertising costs, including the catalogue cost described above. The costs are included in the prepaid expenses and other line of the condensed balance sheets.
Inventory, Policy [Policy Text Block]	Inventories Inventories are valued at the lower of cost, determined on the basis of standard costing, which approximates the first-in, first-out method, or net realizable value. When the Company is the manufacturer, raw materials, labor, and manufacturing overhead are included in inventory costs. The Company records raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing September 30, March 31, 2016 (in thousands) 2016 (in thousands) Finished goods $ 4,484 $ 2,372 Raw materials 1,026 777 $ 5,510 $ 3,149 The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of September 30, 2016 and March 31, 2016, the Company had reserved $285,000 for inventory obsolescence.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists, including the following; (i) a product is shipped under an agreement with a customer; (ii) the risk of loss and title has passed to the customer; (iii) the fee is fixed or determinable; and (iv) collection of the resulting receivable is reasonably assured. The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives. Certain incentive programs require the Company to estimate the number of customers who will actually redeem the incentive based on historical industry experience. As of September 30, 2016 and March 31, 2016, the Company had accrued $105,000 and $151,000, respectively, as an estimate for the foregoing deductions and allowances. These expenses are included in the accrued expenses line of the condensed balance sheets.
Standard Product Warranty, Policy [Policy Text Block]	Warranty and Return Reserves The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation. Based upon the foregoing, the Company has recorded a provision for potential future warranty costs of $119,000 and $117,000 as of September 30, 2016 and March 31, 2016, respectively. The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of September 30, 2016 and March 31, 2016, the Company has recorded a reserve for customer returns of $60,000 and $197,000, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, “Leases.” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The adoption of this ASU is expected to result in all operating leases being capitalized and a current and long-term liability recorded in the Company’s financial statements. In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes,” which requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position to simplify the presentation of deferred income taxes. The standard is effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The Company has early adopted this ASU and had no material impact on our financial statements. In August 2015, the FASB issued ASU 2015-14 which updated (to defer the effective date by one year) previously issued ASU 2014-09, “Revenue from Contracts with Customers,” which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018 using one of two prescribed retrospective methods. Early adoption is not permitted. We have not yet selected a transition method, nor have we determined the effect of the standard on our ongoing financial reporting. In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory.” Under this ASU, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The ASU defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. Management has early adopted ASU 2015-11 and notes no material impact on the Company’s financial position or results of operations. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” which requires management to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued. This ASU is effective for annual periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016. The adoption of this ASU is not expected to have a material impact on the Company’s financial statements.

2. Liquidity and Basis of Pre16

2. Liquidity and Basis of Presentation (Tables)	6 Months Ended
	Sep. 30, 2016
Disclosure Text Block [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The table below summarizes the fair value and carry value of each Level 3 category liability: September 30, 2016 (in thousands) March 31, 2016 (in thousands) Fair Value Carry Value Fair Value Carry Value Liabilities Notes payable-related party $ 2,716 $ 2,759 $ 1,277 $ 1,293 Derivative warrant liability 1,547 1,547 644 644 Sale of intellectual property liability 104 138 117 160 Total $ 4,367 $ 4,444 $ 2,038 $ 2,097
Schedule of Advertising Expenses [Table Text Block]	Advertising expense for the three and six months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, (in thousands) Six Months Ended September 30, (in thousands) 2016 2015 2016 2015 Direct-to-consumer $ 36 $ 61 $ 115 $ 198 Retail 107 95 302 96 Other 7 11 15 24 Total advertising expense $ 150 $ 167 $ 432 $ 318
Schedule of Inventory, Current [Table Text Block]	Inventories are valued at the lower of cost, determined on the basis of standard costing, which approximates the first-in, first-out method, or net realizable value. When the Company is the manufacturer, raw materials, labor, and manufacturing overhead are included in inventory costs. The Company records raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity as prescribed under ASC 330 Inventory Pricing. A majority of the Company’s products are manufactured overseas and are recorded at standard cost which includes product costs for purchased and manufactured products, and freight and transportation costs for inbound freight from manufacturers. September 30, March 31, 2016 (in thousands) 2016 (in thousands) Finished goods $ 4,484 $ 2,372 Raw materials 1,026 777 $ 5,510 $ 3,149

3. Notes Payable, Long Term D17

3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Tables)	6 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	As of September 30, 2016 and March 31, 2016, the outstanding balance of the Company’s notes payable and debt, including accrued interest, is as follows: September 30, 2016 (in thousands) March 31, 2016 (in thousands) Notes payable-related party $ 2,759 $ 1,293 Derivative warrant liability (see Note 4) 1,547 644 Sale of intellectual property liability (see Note 4) 138 160 Total debt 4,444 2,097 Less notes payable and current portion – long term debt 4,444 2,097 Long term debt $ - $ -

5. Equity Compensation Plans (T

5. Equity Compensation Plans (Tables)	6 Months Ended
	Sep. 30, 2016
Share-based Arrangements with Employees and Nonemployees [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	Information regarding all stock options outstanding under the 2005 Plan as of September 30, 2016 is as follows: OPTIONS OUTSTANDING OPTIONS EXERCISABLE Exercise price Options (in thousands) Weighted-average Remaining Contractual Life (years) Weighted-average Exercise Price Aggregate Intrinsic Value (in thousands) Options (in thousands) Weighted-average Remaining Contractual Life (years) Weighted- average Exercise Price Aggregate Intrinsic Value (in thousands) $ 1.01 79 1.35 $ 1.01 79 1.35 $ 1.01 $ 1.10 50 1.50 $ 1.10 50 1.50 $ 1.10 $ 1.21 50 1.50 $ 1.21 50 1.50 $ 1.21 $ 1.55 212 3.88 $ 1.55 140 3.88 $ 1.55 $ 2.20 162 1.99 $ 2.20 162 1.99 $ 2.20 $ 2.42 10 2.02 $ 2.42 10 2.02 $ 2.42 $ 5.31 93 2.85 $ 5.31 93 2.85 $ 5.31 656 2.57 $ 2.13 $ 1,628 584 2.41 $ 2.20 $ 1,417

8. Stockholders_ Equity (Tables

8. Stockholders’ Equity (Tables)	6 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	A summary of the Company’s common stock warrant activity for the period from April 1, 2016 through September 30, 2016 is presented below: Warrants Outstanding (in thousands) Weighted Average Exercise Price Aggregate Intrinsic Value (in thousands) Outstanding, April 1, 2016 444 $ 6.45 $ 7 Granted - - Exercised 12 2.10 Expired - - Outstanding, September 30, 2016 432 $ 6.57 $ 91
Schedule of Stockholders Equity [Table Text Block]	As of September 30, 2016, the Company had the following outstanding warrants to purchase shares of its common stock: Weighted Average Warrants Outstanding (in thousands) Exercise Price Remaining Life (Years) 38 $ 2.10 2.02 394 $ 7.00 0.53 432 $ 6.57 0.66

2. Liquidity and Basis of Pre20

2. Liquidity and Basis of Presentation (Details) - USD ($)	3 Months Ended		4 Months Ended	6 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jan. 31, 2016	Sep. 30, 2016	Sep. 30, 2015	Mar. 31, 2016	Jul. 15, 2016	Apr. 22, 2013
2. Liquidity and Basis of Presentation (Details) [Line Items]
Cash, FDIC Insured Amount	$ 250,000			$ 250,000
Fair Value Inputs, Discount Rate				15.00%
Derivative Liability, Current	1,547,000			$ 1,547,000		$ 644,000
Allowance for Doubtful Accounts Receivable						14,000
Other receivable, reserve percentage of credit card sales				5.00%
Other Receivables, Net, Current	85,000			$ 85,000		232,000
Deferred Advertising Costs	1,000,000			1,000,000		24,000,000
Inventory Valuation Reserves	285,000			285,000		285,000
Other Accrued Liabilities	105,000			105,000		151,000
Provision for Future Warranty Costs	119,000			119,000		117,000
Allowance for Sales Returns [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Customer Refund Liability, Current	60,000			$ 60,000		$ 197,000
Employee Stock Option [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)				656,000
Warrant [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)				432,000
Technology License Agreement [Member] | Scotts Miracle-Gro Company [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Allowance for Doubtful Accounts Receivable	$ 17,000			$ 17,000
Supplier Concentration Risk [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage	233.20%
Cost of Goods Sold	$ 3,600,000
Notes Payable, Other Payables [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Debt Instrument, Face Amount							$ 6,000,000
Sales Revenue, Net [Member] | Seasonal Revenue [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage			70.90%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Major Customer 1 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage	33.30%	42.40%		34.60%	40.10%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Major Customer 2 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage	20.10%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Major Customer 3 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage	16.80%
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage		206.20%
Cost of Goods Sold		$ 2,200,000
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member] | Major Supplier 1 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage		29.10%		142.30%	43.30%
Cost of Goods Sold		$ 315,000		$ 4,100,000	$ 2,600,000
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member] | Major Supplier 2 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage		15.40%
Cost of Goods Sold		$ 167,000
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member] | Major Supplier 3 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage		13.70%
Cost of Goods Sold		$ 149,000
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Major Customer 1 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage				35.30%		35.30%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Major Customer 2 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage				26.20%		22.10%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Major Customer 3 [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Concentration Risk, Percentage				21.30%
Maximum [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Returns Reserves Allowance, Percentage	2.00%			2.00%
Maximum [Member] | Scotts Miracle-Gro Company [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Equity Method Investment, Ownership Percentage								80.00%
Minimum [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Returns Reserves Allowance, Percentage	1.00%			1.00%

2. Liquidity and Basis of Pr

2. Liquidity and Basis of Presentation (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016
Liabilities
Notes payable-related party	$ 2,716	$ 1,277
Notes payable-related party	2,759	1,293
Derivative warrant liability	1,547	644
Derivative warrant liability	1,547	644
Sale of intellectual property liability	104	117
Sale of intellectual property liability	138	160
Total	4,367	2,038
Total	$ 4,444	$ 2,097

2. Liquidity and Basis of 22

2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expenses - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expenses [Line Items]
Advertising expense	$ 150	$ 167	$ 432	$ 318
Direct-to-consumer [Member]
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expenses [Line Items]
Advertising expense	36	61	115	198
Retail [Member]
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expenses [Line Items]
Advertising expense	107	95	302	96
Other Advertising [Member]
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expenses [Line Items]
Advertising expense	$ 7	$ 11	$ 15	$ 24

2. Liquidity and Basis of 23

2. Liquidity and Basis of Presentation (Details) - Schedule of Inventory - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016
Schedule of Inventory [Abstract]
Finished goods	$ 4,484	$ 2,372
Raw materials	1,026	777
	$ 5,510	$ 3,149

3. Notes Payable, Long Term D24

3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 15, 2016	Sep. 30, 2016	Mar. 31, 2016	May 31, 2015
3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Details) [Line Items]
Derivative Liability, Current		$ 1,547	$ 644
Debt, Current		138	160
Other Liabilities		263	$ 579
Notes Payable, Other Payables [Member]
3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount	$ 6,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Scotts Miracle-Gro Company [Member] | Notes Payable, Other Payables [Member]
3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount	$ 6,000
Debt Instrument, Description	The proceeds will be made available as needed in increments of $500,000 not to exceed $6.0 million
Debt Instrument, Maturity Date	Apr. 15, 2017
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument, Payment Terms	The Term Loan may be prepaid from time to time, in whole or in part, in an amount greater than or equal to $250,000, without penalty or premium
Notes Payable		$ 2,800
Paid in Kind Interest, Price Per Share (in Dollars per share)		$ 1.51
Dividends Payable		$ 454		$ 905

3. Notes Payable, Long Term

3. Notes Payable, Long Term Debt and Current Portion -Long Term Debt (Details) - Schedule of Debt - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016
Schedule of Debt [Abstract]
Notes payable-related party	$ 2,759	$ 1,293
Derivative warrant liability (see Note 4)	1,547	644
Sale of intellectual property liability (see Note 4)	138	160
Total debt	4,444	2,097
Less notes payable and current portion – long term debt	4,444	2,097
Long term debt	$ 0	$ 0

4. Scotts Miracle-Gro Transac26

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	Apr. 22, 2013	Sep. 30, 2016	Mar. 31, 2016
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Preferred Stock, Convertible, Conversion Price (in Dollars per share)	$ 1.51
Derivative Liability, Current		$ 1,547	$ 644
Scotts Miracle-Gro Company [Member] | Series B Preferred Stock [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	2,649,007
Shares Issued, Price Per Share (in Dollars per share)	$ 0.001
Stock Issued During Period, Value, New Issues	$ 4,000
Proceeds from Issuance of Convertible Preferred Stock	$ 3,800
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	2,649,007
Preferred Stock, Convertible, Conversion Price (in Dollars per share)	$ 1.51
Preferred Stock, Dividend Rate, Percentage	8.00%
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in Dollars per share)	$ 1.51
Convertible Preferred Stock, Terms of Conversion	The Series B Convertible Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Convertible Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Convertible Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Convertible Preferred Stock and such exercise of the Warrant.
Class of Warrant or Rights, Term of Warrant or Rights	5 years
Class of Warrant or Rights, Exercise Price, Description	(a) an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant),by(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.
Scotts Miracle-Gro Company [Member] | Maximum [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Equity Method Investment, Ownership Percentage	80.00%
Main Power Promissory Note [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Repayments of Debt	$ 950

5. Equity Compensation Plans (D

5. Equity Compensation Plans (Details) - Equity Compensation Plan (2005 Plan) [Member] - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Sep. 30, 2016
5. Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	212,000	212,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares			72,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)			$ 60,000

5. Equity Compensation Plans

5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Options Outstanding (in Shares) | shares	656
Options Outstanding, Weighted-average Remaining Contractual Life	2 years 208 days
Options Outstanding, Weighted-average Exercise Price	$ 2.13
Options Outstanding, Aggregate Intrinsic Value (in Dollars) | $	$ 1,628
Options Exercisable (in Shares) | shares	584
Options Exercisable, Weighted-average Remaining Contractual Life	2 years 149 days
Options Exercisable, Weighted-average Exercise Price	$ 2.20
Options Exercisable, Aggregate Intrinsic Value (in Dollars) | $	$ 1,417
Options Exercise Price $1.01 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 1.01
Options Outstanding (in Shares) | shares	79
Options Outstanding, Weighted-average Remaining Contractual Life	1 year 127 days
Options Outstanding, Weighted-average Exercise Price	$ 1.01
Options Exercisable (in Shares) | shares	79
Options Exercisable, Weighted-average Remaining Contractual Life	1 year 127 days
Options Exercisable, Weighted-average Exercise Price	$ 1.01
Options Exercise Price $1.10 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 1.10
Options Outstanding (in Shares) | shares	50
Options Outstanding, Weighted-average Remaining Contractual Life	1 year 6 months
Options Outstanding, Weighted-average Exercise Price	$ 1.10
Options Exercisable (in Shares) | shares	50
Options Exercisable, Weighted-average Remaining Contractual Life	1 year 6 months
Options Exercisable, Weighted-average Exercise Price	$ 1.10
Options Exercise Price $1.21 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 1.21
Options Outstanding (in Shares) | shares	50
Options Outstanding, Weighted-average Remaining Contractual Life	1 year 6 months
Options Outstanding, Weighted-average Exercise Price	$ 1.21
Options Exercisable (in Shares) | shares	50
Options Exercisable, Weighted-average Remaining Contractual Life	1 year 6 months
Options Exercisable, Weighted-average Exercise Price	$ 1.21
Options Exercise Price $1.55 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 1.55
Options Outstanding (in Shares) | shares	212
Options Outstanding, Weighted-average Remaining Contractual Life	3 years 321 days
Options Outstanding, Weighted-average Exercise Price	$ 1.55
Options Exercisable (in Shares) | shares	140
Options Exercisable, Weighted-average Remaining Contractual Life	3 years 321 days
Options Exercisable, Weighted-average Exercise Price	$ 1.55
Options Exercise Price $2.20 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 2.20
Options Outstanding (in Shares) | shares	162
Options Outstanding, Weighted-average Remaining Contractual Life	1 year 361 days
Options Outstanding, Weighted-average Exercise Price	$ 2.20
Options Exercisable (in Shares) | shares	162
Options Exercisable, Weighted-average Remaining Contractual Life	1 year 361 days
Options Exercisable, Weighted-average Exercise Price	$ 2.20
Options Exercise Price $2.42 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 2.42
Options Outstanding (in Shares) | shares	10
Options Outstanding, Weighted-average Remaining Contractual Life	2 years 7 days
Options Outstanding, Weighted-average Exercise Price	$ 2.42
Options Exercisable (in Shares) | shares	10
Options Exercisable, Weighted-average Remaining Contractual Life	2 years 7 days
Options Exercisable, Weighted-average Exercise Price	$ 2.42
Options Exercise Price $5.31 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price	$ 5.31
Options Outstanding (in Shares) | shares	93
Options Outstanding, Weighted-average Remaining Contractual Life	2 years 310 days
Options Outstanding, Weighted-average Exercise Price	$ 5.31
Options Exercisable (in Shares) | shares	93
Options Exercisable, Weighted-average Remaining Contractual Life	2 years 310 days
Options Exercisable, Weighted-average Exercise Price	$ 5.31

6. Income Taxes (Details)

6. Income Taxes (Details) - USD ($)	6 Months Ended	12 Months Ended
	Sep. 30, 2016	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Deferred Tax Asset, Net, Valuation Allowance, Percent	100.00%	100.00%
Unrecognized Tax Benefits	$ 0	$ 0

7. Related Party Transactions (

7. Related Party Transactions (Details) - Notes Payable, Other Payables [Member] $ in Millions	Jul. 15, 2016USD ($)
7. Related Party Transactions (Details) [Line Items]
Debt Instrument, Face Amount	$ 6
Debt Instrument, Interest Rate, Stated Percentage	10.00%

8. Stockholders_ Equity (Detail

8. Stockholders’ Equity (Details) - USD ($)	Apr. 22, 2013	Sep. 30, 2016	Mar. 31, 2016
8. Stockholders’ Equity (Details) [Line Items]
Preferred Stock, Par or Stated Value Per Share		$ 0.001	$ 0.001
Preferred Stock, Convertible, Conversion Price	$ 1.51
Scotts Miracle-Gro Company [Member]
8. Stockholders’ Equity (Details) [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 0.001
Scotts Miracle-Gro Company [Member] | Series B Preferred Stock [Member]
8. Stockholders’ Equity (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	2,649,007
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	2,649,007
Preferred Stock, Convertible, Conversion Price	$ 1.51
Preferred Stock, Dividend Rate, Percentage	8.00%
Dividends Payable (in Dollars)		$ 478,000

8. Stockholders_ Equity (Det

8. Stockholders’ Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Warrants Outstanding | shares	444
Warrants Outstanding, Weighted Average Exercise Price | $ / shares	$ 6.45
Warrants Outstanding, Aggregate Intrinsic Value | $	$ 7
Granted | shares	0
Granted | $ / shares	$ 0
Exercised | shares	12
Exercised | $ / shares	$ 2.10
Expired | shares	0
Expired | $ / shares	$ 0
Warrants Outstanding | shares	432
Warrants Outstanding, Weighted Average Exercise Price | $ / shares	$ 6.57
Warrants Outstanding, Aggregate Intrinsic Value | $	$ 91

8. Stockholders_ Equity (D33

8. Stockholders’ Equity (Details) - Schedule of Warrants Outstanding - $ / shares shares in Thousands	6 Months Ended
	Sep. 30, 2016	Mar. 31, 2016
8. Stockholders’ Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	432	444
Weighted Average Exercise Price	$ 6.57	$ 6.45
Weighted Average Remaing Life (Yrs)	240 days
Warrants Exercisable at $2.10 [Member]
8. Stockholders’ Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	38
Weighted Average Exercise Price	$ 2.10
Weighted Average Remaing Life (Yrs)	2 years 7 days
Warrants Exercisable at $7.00 [Member]
8. Stockholders’ Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	394
Weighted Average Exercise Price	$ 7
Weighted Average Remaing Life (Yrs)	193 days

Note 9 - Subsequent Events (Det

Note 9 - Subsequent Events (Details) - Notes Payable, Other Payables [Member] - Subsequent Event [Member] $ in Millions	1 Months Ended
	Nov. 10, 2016USD ($)
Note 9 - Subsequent Events (Details) [Line Items]
Proceeds from Issuance of Debt	$ 2.5
Debt Instrument, Description	the proceeds were made available in increments of at least $500,000
Debt Instrument, Maturity Date	Apr. 15, 2017
Notes Payable	$ 5.3